BP1115

Bicalutamide

British Pharmacopoeia (BP) Reference Standard

• Szinonimák: Bicalutamide (CDX), Casodex, Cosudex, N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
• Tapasztalati képlet (Hill-képlet): C₁₈H₁₄F₄N₂O₄S
• CAS-szám: 90357-06-5
• Molekulatömeg: 430.37
• MDL-szám: MFCD00869971
• UNSPSC kód: 41116107
• NACRES: NA.24

Tulajdonságok

• grade: pharmaceutical primary standard
• API-család: bicalutamide
• Forma: solid
• eltarthatósági idő: limited shelf life, expiry date on the label
• gyártó/kereskedő neve: BP
• alkalmazás(ok): pharmaceutical; pharmaceutical small molecule
• Formátum: neat
• tárolási hőmérséklet: 2-8°C
• SMILES string: CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F
• InChI: 1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)
• Nemzetközi kémiai azonosító kulcs: LKJPYSCBVHEWIU-UHFFFAOYSA-N
• Géninformáció: human ... AR(367)

Leírás

Általános leírás

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Alkalmazás

Bicalutamide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Bicalutamide Tablets

Biokémiai/fiziológiai hatások

Bicalutamide (CDX) is a non-steriodal Androgen Receptor (AR) antagonist and a pure antiandrogen. It acts via balancing histone acetylation/deacetylation and recruitment of coregulators. Bicalutamide (CDX) abolishes androgen-mediated expression. For example, MMP13 upregulation in prostate cancer, PLZF (promyelocytic leukemia zinc finger protein), and GADD45γ (growth arrest and DNA damage inducible, gamma). Bicalutamide (CDX) is inhibited by non-genomic, transcription-independent stimulation of PI3K/AKT phosphorylation by androgens.

Kiszerelés

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Egyéb megjegyzések

Sales restrictions may apply.

Biztonsági adatok

• Piktogramok: GHS08,GHS09
• Figyelmeztetés: Danger
• Figyelmeztető mondatok: H351,H360FD,H410
• Óvintézkedésre vonatkozó mondatok: P202 - P273 - P280 - P308 + P313 - P391 - P405
• Veszélyességi osztályok: Aquatic Chronic 1 - Carc. 2 - Repr. 1B
• Tárolási osztály kódja: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Lobbanási pont (F): Not applicable
• Lobbanási pont (C): Not applicable